iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson’s – Pharmaceutical Business review –

Published: 01/20/2026

tags

Latest News

NEWS 01.20.2026

Healios Files Japan Trial Plan for Global Phase 3 ARDS Stem Cell Study – TipRanks

NEWS 01.20.2026

Researchers Find New Hope For Heart Failure Treatment – indica News

NEWS 01.20.2026

Regentis’ GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method – FinancialContent

NEWS 01.20.2026

Isolating and Characterizing Lipocartilage in Mice – Bioengineer.org